SAN DIEGO—Treatments do exist that can improve the prospects of a patient with the rare disease amyloidosis, but only if clinicians keep the disease in mind and treat the patient before it’s too late, an expert said at the 2017 ACR/ARHP Annual Meeting this past November. He also discussed research that may be close to…
![](https://www.the-rheumatologist.org/wp-content/uploads/2018/03/THR_0318_pg32a-150x150.png)